Literature DB >> 11271305

Effect of immunosuppressive agents FK 506 and cyclosporin and steroids on the expression of IL-6 and its receptor by stimulated lymphocytes and monocytes.

A Moutabarrik1, I Nakanishi, S Takahara, K Hachim, M G Bengahnem, B Ramadani, M Ishibashi, D Zaid.   

Abstract

The interaction of interleukin-6 (IL-6) with its receptor (IL-6R) is not well understood. In the present study, we investigated the effect of different immunosuppressive agents on the expression of the couple IL-6/IL-6R on cultured lymphocytes and monocytes. IL-6 in culture supernatants from cultured monocytes were analyzed by ELISA. The expression of IL-6R was studied by flow cytometry. Dexamethazone, cyclosporin (CyA), and FK 506 at immunosuppressive concentrations induced a dose-dependent inhibition of IL-6 secretion from adherent monocytes (MO) stimulated with phytohemagglutinin (PHA). Dexamethazone was the most effective agent in inhibiting IL-6 secretion, while the inhibitory effect observed with 1 ng/ml FK 506 was comparable with that obtained with 100 ng/ml CyA. Unstimulated MO strongly expressed IL-6R (80% positive cells). Stimulation of MO with PHA resulted in a significant downregulation of IL-6R expression. Treatment of PHA-stimulated adherent MO with different concentrations of CyA and FK 506 induced a restoration of IL-6R expression. FK 506 was 100 time more effective in restoring IL-6R than CyA. This restoration of IL-6R was incomplete. FK 506, CyA, and steroids may exert their immunosuppressive effect by inhibiting IL-6 secretion and partially restoring MO IL-6R, which may be important in protecting the cell target against IL-6 autocrine stimulation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 11271305     DOI: 10.1111/j.1432-2277.1994.tb01441.x

Source DB:  PubMed          Journal:  Transpl Int        ISSN: 0934-0874            Impact factor:   3.782


  3 in total

1.  Sputum cytokine levels in patients undergoing hematopoietic SCT and comparison with healthy subjects and COPD: a pilot study.

Authors:  C Moermans; C Bonnet; E Willems; F Baron; M Nguyen; M Henket; J Sele; J-L Corhay; Y Beguin; R Louis
Journal:  Bone Marrow Transplant       Date:  2014-07-28       Impact factor: 5.483

2.  A single-center report of COVID-19 disease course and management in liver transplanted pediatric patients.

Authors:  Muhammed Yuksel; Hacer Akturk; Ozlem Mizikoglu; Ertug Toroslu; Cigdem Arikan
Journal:  Pediatr Transplant       Date:  2021-06-02

3.  Discovery and Characterization of a Potent Interleukin-6 Binding Peptide with Neutralizing Activity In Vivo.

Authors:  Sheila Ranganath; Ashok Bhandari; Nicole Avitahl-Curtis; Jaimee McMahon; Derek Wachtel; Jenny Zhang; Christopher Leitheiser; Sylvie G Bernier; Guang Liu; Tran T Tran; Herodion Celino; Jenny Tobin; Joon Jung; Hong Zhao; Katie E Glen; Chris Graul; Aliesha Griffin; Wayne C Schairer; Carolyn Higgins; Tammi L Reza; Eva Mowe; Sam Rivers; Sonya Scott; Alex Monreal; Courtney Shea; Greg Bourne; Casey Coons; Adaline Smith; Kim Tang; Ramya A Mandyam; Jaime Masferrer; David Liu; Dinesh V Patel; Angelika Fretzen; Craig A Murphy; G Todd Milne; Mark L Smythe; Kenneth E Carlson
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.